NEW YORK (Reuters Health) – When allergic asthma in children can’t be controlled with medium- to high-dose corticosteroids, add-on omalizumab is effective and well tolerated, new research shows.…
NEW YORK (Reuters Health) – More than a third of patients undergoing routine outpatient endoscopic procedures are at high risk for obstructive sleep apnea (OSA), according to findings…
NEW YORK (Reuters Health) – For diagnosing pulmonary embolism, single-photon emission CT (SPECT) lung scintigraphy is a viable alternative to CT pulmonary angiography (CTPA), and it offers advantages…
NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a…
NEW YORK (Reuters Health) – The risk of venous thromboembolism (VTE) after surgery is probably higher and longer-lasting than previously thought, data from the UK’s Million Women Study…
NEW YORK (Reuters Health) – New research suggests that when noncalcified lung nodules are detected by computed tomography (CT), assessment of their volume and volume-doubling time with repeat…
NEW YORK (Reuters Health) – In patients with suspected pulmonary embolism (PE), computed tomographic angiography (CTA) is more than twice as likely to show an unexpected nodule or…
NEW YORK (Reuters Health) – Catheter-directed therapy is an effective treatment for acute massive pulmonary embolism (PE) and the risk of major complications is relatively small, the results…
NEW YORK (Reuters Health) – Keeping hypoxic patients with acute respiratory distress syndrome (ARDS) in the prone position does not reduce mortality, although it might provide a slight…
NEW YORK (Reuters Health) – Long-term ambrisentan therapy safely improves exercise capacity in patients with pulmonary arterial hypertension (PAH), according to results of an extension protocol that followed…